BluGlass: GaN laser performance and the route to manufacturing contracts

More power from a single GaN chip

BluGlass reached 1,250 milliwatts of output from a single gallium nitride laser chip while maintaining single-spatial-mode operation, a result announced on Mar 11, 2025. The device combined a blue, 450-nanometre master oscillator with a power amplifier in one monolithic chip. Its output exceeded the company’s previously reported 750-milliwatt performance by about 67%. Australian Manufacturing covered the result on Mar 12, 2025, retaining the company’s attribution for its record claim. The development formed part of BluGlass’s work on visible lasers for applications including quantum sensing, aviation, communications and underwater light detection and ranging, or LiDAR.

The company described the result as the highest known published performance of its kind, covering both commercial and academic work. That claim had a defined research basis: BluGlass and the University of California, Santa Barbara had conducted literature searches, with a Web of Science search dated Jan 21, 2025 identified in the announcement’s references. Chief executive Jim Haden linked the achievement to the integration of the oscillator and amplifier, which he said increased power with minimal additional beam distortion or noise. The company’s record description therefore belongs to a dated technical announcement and its stated literature review, rather than an independently certified comparison with every subsequent device.

BluGlass also increased output from a separate distributed-feedback laser architecture to 450 milliwatts while maintaining near-single-frequency emission and high side-mode suppression. The earlier output was in the 100-milliwatt range. This DFB-MOPA device also combined a 450-nanometre blue laser and amplification on one chip. The two March achievements retain different specifications: the 1,250-milliwatt result concerns single-spatial-mode output, while the 450-milliwatt result adds the near-single-frequency qualification. The wavelength of 450 nanometres describes the light, whereas 450 milliwatts describes output power. Keeping those units and operating qualifications separate preserves the actual scope of each development.

Integration and wafer-scale design

The master oscillator power amplifier, abbreviated MOPA, places the originating laser and amplification functions within an integrated architecture. BluGlass used a monolithic chip for its March single-mode result and a DFB-MOPA configuration for its narrow-linewidth work. Haden associated monolithic integration with opportunities to improve size, weight and cost and to eliminate several downstream packaging steps. He also described manufacturing these intricate devices as a company capability. Those anticipated packaging advantages accompanied the measured output announcements; BluGlass did not attach a verified factory-wide cost reduction, production yield or units-per-hour figure to the March power milestone.

The DFB devices were being designed for wafer-scale fabrication, with the objectives of reducing downstream optical complexity and cost, supporting greater production volume and producing smaller devices. In the Mar 11, 2025 ASX announcement, BluGlass connected that development direction with quantum technologies and computing. Its target applications required combinations of power, precision and tunability. Wafer-scale design remained a manufacturing objective attached to the device programme. It was distinct from a quantified claim that a production line had already reached a particular volume or that all customer applications had completed qualification.

At Photonics West in January 2025, BluGlass presented GaN distributed-feedback technology and device architectures intended for wafer-scale fabrication. Its demonstrated capabilities included near-single-frequency emission across violet to aquamarine wavelengths, side-mode suppression ratios above 40 decibels and spectral linewidths below three picometres. A monolithically integrated MOPA achieved the earlier 750-milliwatt single-spatial-mode result. These January capabilities supplied the technical background to the March developments. The different measurements describe output, spectral properties and device architecture; they should remain attached to their respective devices and demonstrations rather than being combined into a specification for one universally available laser product.

A manufacturing platform across two countries

BluGlass operates in Australia and the United States, including a purpose-built production facility in Silicon Valley. Its manufacturing offering spans custom laser development and production, from small batches to medium- and high-volume off-the-shelf products. The company’s visible GaN work serves industrial and research customers alongside defence, aerospace, quantum and biomedical markets. During the financial year ended Jun 30, 2025, it continued fulfilling laser orders and supplying foundry services while progressing development contracts. Those activities place established service and product work alongside programmes that still require technical development and customer engagement.

The development platform combines industry-standard metal-organic chemical vapour deposition, or MOCVD, with BluGlass’s patented low-temperature remote plasma chemical vapour deposition process, RPCVD. The company used both technology routes in work on its proprietary laser platform and contractual milestones. Its activities included advanced device design, integration and fabrication rather than a single output-power experiment. BluGlass described the intended benefits in terms of higher performance and lower cost, while continuing to validate RPCVD for commercial acceptance. The presence of a proprietary process and operating production facilities did not remove the further development work identified in the company’s own business programme.

BluGlass’s laser portfolio extends across the visible violet-to-green spectrum. Its customers include original equipment manufacturers, government agencies, research institutions and start-ups, with development projects tailored to specific requirements. During FY2025, the company worked on high-fidelity lasers and advanced integration while continuing its foundry business. Its commercial approach included both custom work and products, with potential manufacturing supply agreements following development projects. These are separate activities within the same platform: a research milestone concerns a device capability, a foundry contract concerns services, and a product order concerns an identifiable supply transaction. The financial accounts distinguish their associated revenue categories.

Development partners and customer work

North Carolina State University selected BluGlass for a second-year visible-laser development subcontract within the Commercial Leap Ahead for Wide Bandgap Semiconductors hub, known as CLAWS. The hub is one of eight innovation hubs in the Department of Defense’s Microelectronics Commons programme. BluGlass worked with the university on advanced DFB modelling to improve designs and performance, alongside its wider visible-laser development activities. The company identified the second-year subcontract among its FY2025 projects. Its participation was a development engagement with defined technical work; any later manufacturing supply opportunities remained separate from the awarded research and development activity.

Uviquity, a venture-backed photonics company, entered a joint development programme with BluGlass for integrated photonic chips. The partners aimed to combine their technologies in heterogeneously integrated photonic integrated circuits, abbreviated HIPIC. BluGlass secured an order for the first phase and identified the potential for at least two further phases of non-recurring engineering work. Those additional phases were opportunities with potential revenue rather than completed awards. The programme added another application for BluGlass’s integration and laser-development capabilities, with its commercial progression tied to the multi-phase development arrangement instead of a single announcement of volume product shipments.

Other customer work involved both government research and university photonics laboratories. BluGlass became an approved supplier of specialist GaN lasers to the Ministry of Defence in India, receiving an initial purchase order from the Solid State Physics Laboratory for fabrication-process benchmarking. The College of Optics and Photonics at the University of Central Florida, CREOL, placed a repeat order for semi-custom GaN laser diode bars after trials using the bars in a coherent beam-combining array. That research combines multiple beams; it is a different arrangement from the single-chip output demonstrated in BluGlass’s March milestone.

LiDAR projects and the commercial pipeline

In October 2024, BluGlass joined Macquarie University and Aurizn in a project to develop and test a laser-based method for measuring subsurface water temperature and depth. BluGlass’s role was to provide visible GaN lasers. The programme envisaged commercial trials of blue ocean LiDAR for maritime situational awareness, including defence and environmental applications. Underwater-object detection and improved climate modelling were among the intended uses. The project’s development and trial objectives describe the work being pursued; they do not establish that a finished sensing system had already been deployed or had achieved a particular range, accuracy or operating lifetime.

BluGlass organised its wider commercial efforts around a project-to-product strategy. Development agreements and long-term programmes could lead to follow-on manufacturing supply arrangements, with opportunities spanning quantum technologies, defence, aerospace, consumer electronics and biomedical applications. In its business review filed on Aug 27, 2025, the company identified 29 active large-scale opportunities with a combined potential value above US$100 million. They ranged from early inception to final negotiations. That spread of stages matters to the description of the business: the pipeline included prospective work at different levels of maturity, rather than one set of signed contracts awaiting delivery.

The company’s prospective manufacturing relationships therefore sat alongside existing development projects, laser orders and foundry services. BluGlass linked customer engagement to its ability to tailor devices and integration to demanding applications, while acknowledging that complex negotiations take time. Its FY2026 objectives included converting opportunities into large development contracts and securing new and repeat product orders. The US$100 million opportunity figure was expressed in US dollars; the consolidated financial statements used Australian dollars. Both the commercial stage and the currency remain part of the figure’s meaning, preventing the opportunity pipeline from being treated as recognised revenue or guaranteed future cash receipts.

Revenue, other income and the FY2025 result

For the year ended Jun 30, 2025, BluGlass earned consolidated revenue of A$5,451,140, compared with A$4,618,437 a year earlier. Other income totalled A$6,193,877 and finance income A$59,830. Together, revenue and those income categories reached A$11,704,847, an increase of about 16%. The audited financial statements filed on Aug 27, 2025 separate these components. The combined figure includes research-and-development support and other income as well as customer business, making it broader than laser-product sales or the revenue line alone. The reporting period covers the full financial year rather than the March technical-announcement date.

Within revenue, laser-diode projects contributed A$3,391,154, up from A$2,053,102 in FY2024. Laser-diode products generated A$367,560, compared with A$63,837, while foundry services contributed A$1,692,426, down from A$2,501,498. BluGlass recognised project revenue over time and product and foundry-service revenue at a point in time. These categories give a more specific account of the commercial mix than the combined revenue-and-income total. They also preserve the distinction between work performed under development projects and sales of laser products, alongside the separate contribution of foundry customers using the company’s manufacturing capabilities.

The R&D tax rebate accounted for A$6,053,755 of other income in FY2025, compared with A$5,372,680 in FY2024. Other items contributed A$140,122 to the current-year other-income total. BluGlass accrued the FY2025 rebate for eligible development activities and anticipated receipt in the second quarter of FY2026. The cash-flow statement separately recorded A$5,372,680 of R&D tax-rebate receipts during FY2025. Accrued support for the current development year and cash received during that year are different accounting events. The auditor treated the R&D incentive as a key audit matter because eligibility assessment and measurement involved judgement and the amount was material to the financial statements.

Cash requirements and going concern

BluGlass’s consolidated loss increased to A$10,977,894 in FY2025 from A$10,138,866 in the previous year. Net assets fell to A$11,591,285 from A$14,886,073. The group used A$6,150,742 of net cash in operating activities, compared with A$6,950,278 a year earlier, while customer receipts during FY2025 totalled A$6,908,799. These financial results accompanied the technical and customer-development milestones, with continuing expenditure on the platform and business. Lower operating cash outflow did not mean that operations had become cash-generative: the current-year operating balance remained an outflow, and the consolidated result remained a loss.

Plant and equipment purchases used A$1,808,502 of cash, compared with A$1,466,320 in FY2024. Cash proceeds from share issues, net of transaction costs, were A$7,451,688, and net financing cash inflow totalled A$8,400,279 after other financing movements. Cash and cash equivalents at year-end stood at A$5,737,859, against A$5,573,205 a year earlier. These are distinct cash-flow measures: equipment purchases concern investing activity, share issues contribute financing resources, and the closing cash balance follows all relevant movements. They provide the funding context for continued development and manufacturing work without turning a technology milestone into a claim of financial self-sufficiency.

The directors prepared the accounts on a going-concern basis while explicitly identifying a material uncertainty about the group’s ability to continue as a going concern. Their assessment included anticipated R&D rebates, future capital raising, the possibility of financing the following year’s rebate and the ability to scale back a significant portion of development activity if needed. In.Corp Audit & Assurance issued an unmodified audit opinion and drew attention to the uncertainty, citing the loss and operating cash outflows. The auditor did not modify its opinion for that matter. The directors’ confidence and the disclosed uncertainty both remain part of the FY2025 funding position.

Intellectual property and the next development year

BluGlass filed three provisional patent applications for high-power, tunable GaN laser architectures during FY2025. Its intellectual-property portfolio at the business-review date included 51 internationally granted patents, eight patent families and 13 trademarks, together with applications at Patent Cooperation Treaty and provisional stages. An application is a different status from a granted patent. The new work targeted architectures relevant to aerospace and marine applications, quantum sensing and computing, and biomedical uses. These intellectual-property activities accompanied the device-development programme and its manufacturing ambitions, with their filing and grant status retained separately from any claim about completed commercial adoption.

An Industry Advisory Board led by Professor Steven DenBaars and Richard Craig added guidance on technology development, market positioning and commercial partnerships. BluGlass established the board to support its technical roadmap and adoption efforts across quantum, defence and biotechnology markets. The board complemented advice from its existing research and consortium relationships. Its role was advisory, alongside the company’s operational and customer-development work. In the same period, BluGlass continued presenting device capabilities at industry conferences and engaging prospective customers, while progressing its patented process and integration architectures. Those activities formed part of its product and project development rather than a substitute for customer orders or recognised revenue.

BluGlass’s FY2026 programme combined partnership development, new technical capabilities, manufacturing improvement and the pursuit of large development projects. It planned to advance technology roadmaps while continuing to win laser orders and project funding. The March 2025 performance results supplied dated device milestones; the later FY2025 accounts supplied the revenue mix, cash requirements and funding qualifications around that work. The company’s stated objectives remained forward-looking at the August filing date. Their implementation involved both the technical programme and commercial engagement, with each new development phase, product order and manufacturing agreement retaining its own status and financial treatment.

The FY2026 objectives

• Strengthen partnerships with industry, government and defence organisations.
• Advance technical roadmaps and introduce new capabilities.
• Continue improving manufacturing and operations.
• Win large development projects and secure non-dilutive revenue and development funding.